SKYRIZI 180 MG/1.2 ML ON-BODY | Missouri Department of Social Services

Generic Name

RISANKIZUMAB-RZAA

Review Date Began

Tue, 12/27/2022 - 12:00

Review Date Completed

Tue, 02/07/2023 - 12:00

Conclusion

PDL Product

Committee Month

Sat, 04/01/2023 - 12:00